Deals

Novo Nordisk Licenses Hengrui's HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes
DiabetesHengrui Pharmaceuticals

Novo Nordisk Licenses Hengrui’s HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276; HKG: 1276) announced a licensing agreement with Novo Nordisk A/S (NYSE: NVO) for HRS‑1596, an oral candidate with once‑weekly administration potential targeting obesity,…

Novo Nordisk Licenses Nanexa's PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Novo Nordisk Licenses Nanexa’s PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Atavistik Bio Strikes CVRM Collaboration with Roche – USD 70 Million Upfront, up to USD 1.9 Billion in Milestones for Allosteric Small‑Molecule Discovery

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies
BiotechFinance

Jiangsu Nhwa Pharmaceutical Invests in NeuroThree to Develop CNS Therapies

Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China
BayerCancer

Yifan Pharma Secures Rights to Bayer’s Stivarga and Nexavar in China

Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
AIInsilico Medicine

Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
LexenpharmSHA: 688621

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs

Show More